Top Page
Owlet
(NYSE:OWLT)
Owlet (OWLT) vs. SPDR S&P 500 ETF (SPY)
Owlet Business Overview & Revenue Model
Owlet Earnings Call Summary
Owlet Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 89.79M | 78.06M | 54.01M | 69.20M | 75.80M | 75.40M |
| Gross Profit | 47.25M | 39.31M | 22.59M | 23.30M | 35.00M | 35.88M |
| EBITDA | -10.55M | -9.47M | -27.49M | -75.53M | -42.71M | -8.25M |
| Net Income | -47.98M | -12.54M | -32.90M | -79.29M | -71.70M | -10.52M |
Balance Sheet | ||||||
| Total Assets | 63.54M | 49.52M | 44.12M | 58.10M | 140.00M | 40.12M |
| Cash, Cash Equivalents and Short-Term Investments | 21.83M | 20.25M | 16.56M | 11.20M | 95.10M | 17.01M |
| Total Debt | 17.16M | 11.70M | 15.22M | 16.20M | 16.50M | 28.84M |
| Total Liabilities | 108.02M | 66.33M | 73.80M | 68.70M | 84.80M | 60.94M |
| Stockholders Equity | -44.48M | -16.81M | -29.68M | -10.60M | 55.20M | -20.82M |
Cash Flow | ||||||
| Free Cash Flow | -13.52M | -11.97M | -23.59M | -82.97M | -42.62M | -1.19M |
| Operating Cash Flow | -12.71M | -11.21M | -23.53M | -81.40M | -40.60M | -129.00K |
| Investing Cash Flow | -839.00K | -761.00K | -59.00K | -1.60M | -2.00M | -1.06M |
| Financing Cash Flow | 20.31M | 16.04M | 28.91M | -900.00K | 120.60M | 6.46M |
Owlet Technical Analysis
Owlet Risk Analysis
Owlet Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $245.60M | ― | -57.10% | ― | -3.89% | 9.68% | |
| ― | $102.16M | ― | -77.26% | ― | -9.59% | 8.78% | |
| ― | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
| ― | $197.83M | ― | ― | ― | 36.81% | -74.26% | |
| ― | $129.54M | ― | -59.15% | ― | 22.57% | 14.11% | |
| ― | $66.82M | -1.15 | -66.88% | ― | 18.24% | 4.81% | |
| ― | $142.86M | ― | -350.22% | ― | 29.34% | -283.53% |
Owlet Corporate Events
On October 21, 2025, Owlet entered into an underwriting agreement with William Blair & Company, L.L.C. and TD Securities (USA) LLC to issue and sell 4,196,000 shares of its Class A common stock at $7.15 per share. The company plans to use the proceeds to support commercialization, research and development, and general corporate purposes. The agreement includes a 30-day option for underwriters to purchase an additional 629,400 shares. Directors, executive officers, and certain stockholders have agreed to a 90-day lock-up period for selling or transferring stock.
The most recent analyst rating on (OWLT) stock is a Hold with a $8.00 price target. To see the full list of analyst forecasts on Owlet stock, see the OWLT Stock Forecast page.
On October 8, 2025, Owlet, Inc. held its annual stockholders meeting where several key amendments were approved. The stockholders approved an increase of 375,000 shares of Class A common stock under the 2021 Incentive Award Plan and an amendment to the company’s charter to allow for officer exculpation as per Delaware law. Additionally, the election of directors and the ratification of PricewaterhouseCoopers LLP as the independent auditor for 2025 were confirmed. Furthermore, an Exchange Agreement was executed, resulting in the issuance of 5,426,429 new shares of common stock, bringing the total to 22,788,420 shares outstanding as of October 10, 2025.
The most recent analyst rating on (OWLT) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Owlet stock, see the OWLT Stock Forecast page.
On October 1, 2025, Kurt Workman resigned as CEO of Owlet, Inc., transitioning to Executive Chair of the Board, while Jonathan Harris was appointed as the new President and CEO. The transition included compensatory arrangements for both executives, with Workman receiving vested stock units and a cash bonus, and Harris receiving an increased salary and bonus eligibility, reflecting strategic leadership changes aimed at strengthening the company’s market position.
The most recent analyst rating on (OWLT) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Owlet stock, see the OWLT Stock Forecast page.
On September 11, 2025, the United States District Court for the Central District of California preliminarily approved a settlement involving Owlet, Inc. and its directors to resolve a derivative action concerning statements about the Smart Sock. The settlement includes changes to corporate governance practices and a release of claims without any admission of wrongdoing. The settlement’s approval will lead to the dismissal of all claims with prejudice, and Owlet will cover attorney fees, though the amount is yet to be determined.
The most recent analyst rating on (OWLT) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on Owlet stock, see the OWLT Stock Forecast page.
Owlet Inc’s recent earnings call painted a picture of robust financial health, with strong revenue growth and consistent profitability in key metrics. The company celebrated successful product launches and strategic partnerships, which have bolstered its performance. However, challenges such as international revenue declines, increased tariffs, and slow progress in healthcare partnerships were also highlighted.
Owlet, Inc., a pioneer in smart infant monitoring, operates in the healthcare sector offering innovative pediatric wearables and digital health solutions. The company recently announced its financial results for the second quarter of 2025, highlighting a significant revenue increase and a strategic CEO transition. Owlet reported a 25.9% year-over-year revenue growth to $26.1 million, driven by strong sales of its Dream Sock and Dream Duo products. The gross margin improved to 51.3%, and adjusted EBITDA rose to $0.3 million, indicating a positive trend in operational efficiency. Despite a net loss of $37.6 million, largely due to a non-cash stock warrant liability adjustment, the company demonstrated robust performance in its core business and subscription services. The CEO transition plan will see Jonathan Harris take over as CEO, with Kurt Workman moving to Executive Chairman, ensuring continuity in leadership and strategic focus. Looking ahead, Owlet has raised its full-year 2025 guidance, expecting revenue growth between 24% and 28%, and aims to achieve adjusted EBITDA profitability, reflecting confidence in its market position and growth strategy.
On August 7, 2025, Owlet, Inc. entered into an Exchange Agreement with certain holders of its Series A and Series B Warrants to exchange these warrants for newly issued shares of Common Stock. This agreement, which involves exchanging warrants for over 9 million shares for approximately 5.4 million new shares, is subject to stockholder approval and customary closing conditions. The transaction aims to streamline the company’s capital structure and involves significant stakeholders, including Eclipse Ventures LLC and Trilogy Equity Partners, who have agreed to support the proposal at the 2025 Annual Meeting. The agreement includes a lock-up period for the exchanged shares and provisions for registration rights, indicating a strategic move to enhance shareholder value and align interests among key investors.
The most recent analyst rating on (OWLT) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Owlet stock, see the OWLT Stock Forecast page.
Owlet, Inc. announced the resignation of CEO Kurt Workman, effective October 1, 2025, who will transition to Executive Chairman, with Jonathan Harris succeeding him as CEO. The company reported strong financial results for Q2 2025, with a 25.9% increase in revenue year-over-year and improvements in gross margin and adjusted EBITDA, positioning Owlet for continued growth in the pediatric health market.
The most recent analyst rating on (OWLT) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Owlet stock, see the OWLT Stock Forecast page.